Back to search
FDAFDA · Food and drugs·Recall number D-580-2013

Lorazepam, 0.5 mg tablets, 100 count, RX only, Distributed by Major Pharmaceuticals, Livonia, MI. NDC 0904-6007-60

Published June 12, 2013 · Recall initiated: March 27, 2013

Summary

FDA records drug Class III recall D-580-2013, published June 12, 2013 and initiated March 27, 2013. Recalling firm: Legacy Pharmaceutical Packaging LLC; Status: Terminated; Reported quantity: 1,644 bottles; Lot: L-04009 Exp.11/15. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Labeling: Incorrect or Missing Lot and/or Exp Date: Lorazepam Lot # L-04009

What to do

Voluntary: Firm initiated · Letter

Get an email if LORAZEPAM has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
LORAZEPAM
Manufacturer
Legacy Pharmaceutical Packaging LLC
Distributor
Distribution was made to IN.
Lot
L-04009 Exp.11/15
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Lorazepam, 0.5 mg tablets, 100 count, RX only, Distributed by Major Pharmaceuticals, Livonia, MI. NDC 0904-6007-60 recalled?

Yes. FDA published recall D-580-2013 on June 12, 2013. Reported hazard: Labeling: Incorrect or Missing Lot and/or Exp Date: Lorazepam Lot # L-04009

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: LORAZEPAM.